CLNN – clene inc. (US:NASDAQ)
Stock Stats
News
Clene (NASDAQ:CLNN) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Clene (NASDAQ:CLNN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Clene (NASDAQ:CLNN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®
Clene to Provide CNM-Au8® ALS Program Update
Form 8-K Clene Inc. For: Dec 03
Form 8-K Clene Inc. For: Dec 03
Form 4 Clene Inc. For: Nov 13 Filed by: Kiernan Matthew
Form 4 Clene Inc. For: Nov 13 Filed by: Gay Jonathon
Form 4 Clene Inc. For: Nov 13 Filed by: Mosca Alison
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.